Compare AVPT & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVPT | AMPH |
|---|---|---|
| Founded | 2001 | 1996 |
| Country | United States | United States |
| Employees | 3443 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 971.8M |
| IPO Year | N/A | 2005 |
| Metric | AVPT | AMPH |
|---|---|---|
| Price | $10.27 | $17.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | $16.64 | ★ $28.38 |
| AVG Volume (30 Days) | ★ 1.8M | 586.8K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $719,887,000.00 |
| Revenue This Year | $25.00 | $6.90 |
| Revenue Next Year | $19.63 | $4.64 |
| P/E Ratio | $1,348.94 | ★ $129.43 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.84 | $16.65 |
| 52 Week High | $19.95 | $31.26 |
| Indicator | AVPT | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 51.63 | 38.40 |
| Support Level | $9.24 | $17.03 |
| Resistance Level | $10.40 | $24.16 |
| Average True Range (ATR) | 0.55 | 0.88 |
| MACD | -0.00 | -0.32 |
| Stochastic Oscillator | 38.36 | 14.87 |
AvePoint Inc is a provider of modern data protection, enabling organizations to secure, govern, and operationalize data at scale across cloud ecosystems. Customers rely on the AvePoint Confidence Platform to reduce risk, improve operational efficiency, and accelerate digital transformation as it adopt cloud collaboration and artificial intelligence (AI)-driven developed tools and workflows. Its products and services are sold throughout the world, through direct and indirect sales channels.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.